LAUSR

Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK‐mTOR pathway

Sign Up to like & get
recommendations!
0 Published in 2018 at "Life Sciences"

DOI: 10.1016/j.lfs.2018.05.046

Abstract: Aims: AMP‐activated protein kinase (AMPK) functions as a cellular energy sensor regulating various aspects of cellular metabolism. Metformin (Met), an activator of AMPK, has been reported to reduce the cancer risk and enhance antitumor effects… read more here.

Keywords: enhances cisplatin; effect; expression; metformin enhances ... See more keywords